Barinthus Biotherapeutics plc. (BRNS) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $37.0K | -95.9% |
| 2024 | $892.0K | -83.5% |
| 2023 | $5.41M | -11.8% |
| 2022 | $6.14M | +435.6% |
| 2021 | $1.15M | +291.1% |
| 2020 | $293.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $37.0K | -95.9% |
| 2024 | $892.0K | -83.5% |
| 2023 | $5.41M | -11.8% |
| 2022 | $6.14M | +435.6% |
| 2021 | $1.15M | +291.1% |
| 2020 | $293.0K | — |